Skip to main content
Commonwealth of Virginia branding bar cardinal logo

Virginia.gov

A design prototype by Datopian, not an official website

Find a Commonwealth Resource

Daridorexant

HealthData.Gov

Updated Mar 25, 2026

About this dataset

Quviviq (daridorexant) is a prescription medication by Idorsia Pharmaceuticals Ltd, classified as an orexin receptor antagonist. It's used to treat insomnia in adults and comes as oral tablets in 25mg and 50mg strengths. As a Schedule IV controlled substance, it helps promote sleep by blocking orexin receptors. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

  • HTML

    Daridorexant

    Access the FDA dataset for Daridorexant β€” ANDA 203308 submitted by Mylan Institutional LLC

    Modified Dec 27, 2025

Prototype by Datopian Β· not an official government website Β· data from data.virginia.gov